The FDA's draft guidance is supposed to cut the cost and time-associated burden of biosimilar development, despite a mixed ...

Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

AI and ML enhance drug discovery by rapidly screening compounds and predicting ADMET properties, reducing resource commitment and de-risking projects. Digital tools bridge R&D and manufacturing, ...

AI’s true power lies in pattern recognition across messy, real-world data: Natural language processing extracts phenotypes, comorbidities, and device usability feedback from unstructured clinical ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies, ...

Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the ...

Gilead Sciences recently broke ground on a 180,000-square-foot AI-enabled Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus, part of a US$32 billion ...